Pharmaceutical manufacturing companies in Maryland

Emergent BioSolutions

Emergent BioSolutions, headquartered in Gaithersburg, Maryland, is a global leader in the development and manufacturing of specialty biopharmaceuticals. Known for its cutting-edge technologies, the company provides services in the areas of biologics, vaccine development, and contract manufacturing. Emergent BioSolutions specializes in aseptic manufacturing, offering pre-sterilized vials and syringes for injectable drugs, and it is DEA registered for the production of controlled substances.

The company’s expertise in manufacturing biologics and potent compounds has made it a top choice for many major pharmaceutical and biotechnology companies. Emergent BioSolutions’ global reach is bolstered by its high-quality facilities, which include capabilities for process development, manufacturing, and clinical supply. The company’s focus on developing expert-driven processes ensures that each product meets the highest standards of quality and regulatory compliance, including Good Manufacturing Practices (GMP).

Catalent Pharma Solutions

Catalent Pharma Solutions, with a major presence in Maryland, is recognized as one of the leading providers of drug development services in the life sciences industry. With a broad range of capabilities, Catalent specializes in the manufacturing of oral drugs, biologics, and injectables. The company’s state-of-the-art facilities offer fill-finish services and provide precise, aseptic processing to ensure the safe and effective delivery of therapeutics.

Catalent’s technology-driven approach to manufacturing focuses on providing the best in class for both clinical supply and commercial-scale production. The company’s expertise spans across the full product lifecycle, including process development, clinical trial material supply, and technology transfer. As a key player in the industry, Catalent’s Maryland operations cater to a global market, making it a trusted partner for pharmaceutical companies across the world.

Lonza Group

Lonza, with facilities in Walkersville, Maryland, is a leading global provider of contract manufacturing services to the pharmaceutical, biotechnology, and life sciences industries. The company specializes in the production of biologics, including monoclonal antibodies, gene therapies, and cell and gene therapies. Lonza’s services extend across the entire manufacturing process, from pre-clinical development through commercial production.

Lonza’s Maryland facility offers a wide range of capabilities, including drug substance manufacturing, aseptic fill-finish services, and the production of high-potency compounds. With a commitment to quality and compliance with GMP standards, Lonza plays a vital role in helping companies bring innovative therapeutics to market. The company’s global presence, combined with its cutting-edge technology, makes it a top choice for pharmaceutical and biotechnology firms worldwide.

WuXi AppTec

WuXi AppTec is a prominent name in the pharmaceutical manufacturing sector, providing comprehensive services to the pharmaceutical, biotechnology, and medical device industries. With a strong presence in Maryland, WuXi offers an integrated platform that includes drug discovery, development, and manufacturing services. The company’s Maryland facilities focus on process development, clinical supply production, and the manufacture of sterile injectables, biologics, and other therapeutics.

WuXi’s contract manufacturing services are supported by advanced technologies, including non-destructive testing methods, which ensure the integrity and safety of the manufactured products. The company’s ability to provide expert-driven processes, combined with its broad experience in biologics and therapeutics, makes it a leading player in the pharmaceutical manufacturing industry.

Bethesda-based Gaithersburg Pharmaceuticals

Gaithersburg Pharmaceuticals, located in Bethesda, Maryland, is a specialized pharmaceutical manufacturing company focused on producing high-quality injectable and oral drugs. The company provides a full range of contract manufacturing services, including fill-finish services, process development, and the manufacture of pre-sterilized vials and syringes. Their expertise extends to handling potent compounds, biologics, and complex therapeutics.

Gaithersburg Pharmaceuticals operates under GMP guidelines, ensuring that every product meets the rigorous standards set by regulatory agencies. Their Maryland-based facility is equipped with cutting-edge technology and capable of managing clinical trials, scale-up production, and commercial manufacturing.

Viral Vector Services by Altimmune

Altimmune, located in Gaithersburg, Maryland, specializes in the development and manufacturing of viral vectors for gene therapy and vaccines. Their work is critical to the biotechnology and life sciences sectors, where gene therapy holds great promise for the treatment of a variety of diseases. Altimmune’s manufacturing capabilities include the production of high-potency biologics and the provision of viral vector-based vaccines.

The company’s focus on the development and manufacture of biologics and its expertise in viral vector technology places it at the forefront of innovative therapies. Their Maryland facility supports the global supply of gene therapies and vaccines, adhering to GMP standards to ensure the highest level of quality control.

CRISPR Therapeutics

CRISPR Therapeutics, based in Maryland, is an innovative biotechnology company that focuses on gene-editing technologies. While CRISPR Therapeutics is primarily known for its groundbreaking work in gene therapy, the company also plays a significant role in pharmaceutical manufacturing. Their expertise in biologics, cell therapies, and gene-editing technologies has positioned them as a key player in the future of personalized medicine.

Their manufacturing capabilities include the production of cell-based therapeutics and the scale-up of biologic drug substances. As part of their commitment to cutting-edge technology, CRISPR Therapeutics utilizes state-of-the-art aseptic techniques, ensuring the quality and integrity of their gene therapies.

Hikma Pharmaceuticals

Hikma Pharmaceuticals, with a major facility in Maryland, is a global pharmaceutical company specializing in generic and branded injectable medicines. The company’s Maryland-based manufacturing site is equipped to produce injectable drugs, including biologics and other therapeutics. Hikma’s focus on high-quality manufacturing practices, combined with a wide range of capabilities, including sterile and non-sterile injectables, makes it a leading provider of pharmaceutical solutions.

Hikma’s expertise extends to the development and manufacturing of complex formulations and potent compounds. The company is known for its advanced fill-finish services and commitment to producing medicines that meet the highest standards of quality and safety.

MedImmune (AstraZeneca)

MedImmune, the global biologics division of AstraZeneca, is located in Gaithersburg, Maryland. MedImmune is a leader in the development and manufacturing of biologic drugs, including vaccines and monoclonal antibodies. With a focus on biologics, MedImmune’s capabilities include aseptic manufacturing, drug substance production, and fill-finish services.

The company is deeply involved in process development, with expertise in the creation of stable formulations for injectable biologics. As a key player in the biotechnology sector, MedImmune is known for its innovative approaches to drug manufacturing, including the use of advanced technologies such as microsphere technology to enhance the delivery of biologic therapeutics.

Northrop Grumman Innovation Systems

Northrop Grumman Innovation Systems, located in Linthicum, Maryland, has expanded its portfolio to include pharmaceutical manufacturing, focusing on providing services to the biotechnology and pharmaceutical industries. The company’s expertise lies in the use of innovative technologies for the production of sterile injectable drugs, biologics, and drug-delivery systems.

Their Maryland-based facilities are equipped with GMP-certified equipment, allowing Northrop Grumman Innovation Systems to offer high-quality contract manufacturing services, including clinical supply production, process development, and advanced analytical testing.

Paragon Bioservices (Acquired by Catalent)

Paragon Bioservices, now part of Catalent Pharma Solutions, is a Maryland-based company known for its expertise in the production of biologic products, including cell and gene therapies. Paragon Bioservices offers a full range of services, from early-stage process development to commercial-scale manufacturing.

Their Maryland facility specializes in the production of viral vectors, plasmid DNA, and monoclonal antibodies, and it is equipped to handle potent compounds and biologics. With a strong emphasis on precision, scalability, and regulatory compliance, Paragon’s facility in Maryland continues to be a leader in the biotechnology and life sciences sectors.

Kite Pharma (A Gilead Company)

Kite Pharma, a Gilead company, is an innovative biotechnology firm located in Gaithersburg, Maryland. Kite Pharma specializes in cell therapies and gene therapies, offering expertise in the development and manufacture of cell-based immunotherapies for cancer. Their Maryland facility is equipped for the production of autologous T cell therapies and the development of advanced manufacturing processes.

The company’s focus on cutting-edge technologies, including gene editing, cell processing, and biologics manufacturing, positions Kite Pharma as a leading force in the cell and gene therapy sector.

To sum up:

Maryland’s pharmaceutical manufacturing sector is thriving, with a wide variety of companies offering a full spectrum of services to the global life sciences industry. From biologics and potent compounds to sterile injectables and advanced drug-delivery systems, the state is home to top pharmaceutical firms that specialize in the production of life-saving therapeutics.

These companies utilize state-of-the-art technologies, adhere to GMP guidelines, and are driven by expert processes to ensure the quality and safety of every product they produce. As a global hub for pharmaceutical innovation, Maryland continues to play a key role in advancing the industry and providing critical support to pharmaceutical and biotechnology companies worldwide.

ALSO REFER

Executive MBA programs in Chicago